Skip to main content
. 2021 Apr 15;8:656658. doi: 10.3389/fmed.2021.656658

Table 1.

Clinical characteristics of the study population.

Pooled population (n = 261) Mean (SD) NAFLD– (n = 214) Mean (SD) NAFLD+ (n = 47) Mean (SD) P-value (NAFLD– vs. NAFLD+)
Age (years) 66 (10) 67 (10) 63 (9) 0.004
Height (cm) 168 (10) 168 (10) 169 (9) 0.63
Weight (kg) 84 (19) 80 (16) 100 (24) <0.001
BMI (kg/m2) 29.5 (6.3) 28.2 (5.1) 35.1 (8.0) <0.001
Total cholesterol (mmol/l) 4.35 (1.09) 4.33 (1.04) 4.44 (1.31) 0.64
HDL cholesterol (mmol/l) 1.31 (0.40) 1.34 (0.41) 1.13 (0.29) 0.002
LDL cholesterol (mmol/l) 2.40 (0.93) 2.38 (0.90) 2.51 (1.04) 0.47
Triglycerides (mmol/l) 1.57 (0.98) 1.43 (0.76) 2.20 (1.50) 0.003
Glucose (mmol/l) 6.64 (1.81) 6.49 (1.64) 7.33 (2.31) 0.029
Systolic BP (supine, mmHg) 145 (23) 145 (23) 147 (21) 0.50
Diastolic BP (supine, mmHg) 76 (11) 75 (10) 80 (11) 0.004

NAFLD–, subjects without non-alcoholic fatty liver disease; NAFLD+, subjects with non-alcoholic fatty liver disease; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; BP, blood pressure.